Life Sciences & Biotechnology
Research Agricultural
Total number of Record(s): 5525
| Title | Principal Investigator | Start Year | Funding Agency | Focus Area |
|---|---|---|---|---|
| Targeting Beta-arrestin dependent GPCR signaling with highly specific molecular recognition modules as a therapeutic approach in breast cancer | Dr. A.K. Shukla, Associate Professor, Indian Institute of Technology (Kanpur), Uttar Pradesh | 2019 | Department of Bio-Technology, (DBT) | Research & Development, R&D |
| Targeting Deadenylation-Mediated Kinetoplastidae Parasite-Specific Polycistronic Gene Regulation for Therapeutic Intervention | Dr. Pijush Kanti Das, Senior Scientist, Indian Institute of Chemical Biology (IICB), Kolkata | 2016 | Department of Biotechnology (DBT), Govt. of India | Gene Regulation for Therapeutic Intervention |
| Targeting endothelin-1 to mitigate the risk of nitrofibrinogen-governed TE induced by cisplatin chemotherapy | Dr. Gunjan Guha, Associate Professor, SASTRA University, Tamil Nadu | 2018 | Department of Biotechnology (DBT), Government of Inida | Cisplatin chemotherapy |
| Targeting Kennedy pathway of cellular phosphatidylethanolamine biosynthesis as a common therapeutic strategy against protozoan parasites like Leishmania Donovanti, Tryanosoma Brucei & entamoeba Histolytica | Dr. W. Basuball Assistant Professor S.R.M. Institute of Sciences & Technology, Chennai, Tamilnadu Mangalagiri Neerukonda Tadikonda Road, Mangalagiri Andhra Pradesh | 2020 | Department of Science and Technology (DST) | Science & Engineering Research Board - Start-up Research Grant (SERB-SRG) |
| Targeting lysyl oxidase-2 and miRNA for effective gene therapy of liver fibrosis | Dr Chandraiah Godugu, Assistant Professor, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad | 2017 | Department of Science and Technology (DST), New Delhi | Liver fibrosis |
| Targeting n3CLPro main protease, spike surface protein of COVID-19 | Prof. Ashok Patel, Assistant Professor, Indian Institute of Technology (IIT), New Delhi | 2020 | NA | Drug repurposing for COVID-19 |
| Targeting n3CLPro main protease, spike surface protein of COVID-19 In silico screening of FDA approved compounds | Prof Ashok Patel, Assistant Professor, Indian Institute of Technology (IIT) Delhi | 2020 | Insilico identification of covid protein | |
| Targeting neuroinflammation, oxidative nitrosative stress and PARP over activation in experimental model of neuropathic pain | Dr. Ranadeep Gogoi, Assistant Professor, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati | 2014 | Department of Biotechnology (DBT), New Delhi | Pharmacology |
| Targeting of parallel DNA and RNA Gquadruplex structures using small molecule ligands | Dr. Pradeep Kumar, Professor, Department of Chemistry, Indian Institute of Technology (IIT), Mumbai, Maharashtra | 2016 | Science and Engineering Research Board (SERB), Department of Science & Technology (DST), Government of India | DNA and RNA Gquadruplex structures |
| Targeting oxide detoxifying truncated hemoglobin, HnN of mycobacterium tuberculosis for effient drug development against Tuberculosis | Prof. Jagdeep Kaur, Professor, Department of Biotechnology, Panjab University (PU) (PU), Chandigarh, 160014 | 2016 | Science and Engineering Research Board (SERB), Department of Science & Technology (DST), Government of India | Tuberculosis |